Conclusions
Quality assurance as such is mainly a question of attitudes and behaviour. It is difficult to induce doctors to modify their behaviour by pressures other than from inside the profession. In France there are three types of understanding of medical evaluation: that of the official bodies and evaluation units of hospitals, who try to define and disseminate actual quality assurance; that of doctors, who often confuse it with clinical research; and that of government, whose main problem is financial. The fact that, except in the Netherlands, quality assurance has always been promoted by governments or health administrations, or both, and never by the medical profession itself constitutes in the eyes of doctors an original sin that is difficult to overcome. It could also turn against quality assurance itself when governments eventually find out that quantity and quality belong to two different logics and that quality assurance does not necessarily entail savings.
Therefore many problems remain before quality assurance can be integrated routinely in medical practice. Clarification is needed about the concept of quality assurance and the activities actually covered by quality assurance. Clarification is also needed about the government's intentions and its role in developing and managing quality assurance. Ideally, quality assurance should be adopted by the medical profession as an activity of its own, independent of any public or administrative policy. The increasing difficulties experienced by the health service in France are causing doctors, researchers, and the politicians and administrative policy makers to put forward medical evaluation as one of the main remedies for the problems. And yet the evaluation of health care in France is rather more a hope and expectation than a reality. It is true that scientific work, particularly regarding the new technologies and public health, has been performed in France in the past 10 years; but this has been only sporadic action rather than the development of a true health care policy as conceived of in the United States and Great Britain. Moreover, there is still much conceptual confusion regarding evaluation. Bandied about daily in the press and picked up by all the health organisations and professional bodies, the term "health care evaluation" is associated by some with control strategies having an economic finality whereas for others its importance is more professional or ethical, or both. The imprecise use of the term mirrors the multiple difficulties and barriers that the concept generates within the health profession in France. Its courses are many': scientific, psychological, sociological, and cultural.
The time now seems right, however, for health care evaluation to develop in France, owing to the realisation of such a need by most health professionals and political and administrative health care policy makers.
Medical audit, as defined in 1989 by the NHS in Great Britain,2 covers what is beginning to be known in France as "medical evaluation of health care." The aim is to perform a systematic critical analysis of medical care, including the procedures used for diagnosis and treatment, the use of resources, and the resulting outcome and quality of life for the patient. In these terms medical audit in France has been dealt with only sporadically, through individual initiatives and the action of isolated groups, whose results are more often than not published in lesser scientific reviews and whose dissemination is limited to health professionals.
Therefore the scientific literature in the French language has produced in the past 15 years rare articles or basic reports concerning the medical evaluation of health care acts38 and a few publications relating the firsthand experience of a few isolated teams.9'3 A few consensus lectures have been delivered, in no planned order, most of which have raised criticisms of methodology without being communicated to the health professionals directly concerned. 6 This weakness in the production of medical audits in France goes hand in hand with the absence of any structured health policy on audit. Everything therefore points to the development of medical audit becoming a reality in France. However, this cannot come about unless a certain number of conditions are respected: (a) Clearly defining the objectives and insisting that the finality of any audit is first and foremost medical rather than economic; (b) establishing a reliable information gathering system, in structural and financial terms, to dispose ofdata for use in the development of medical audits throughout France; (c) developing professional or institutional encouragement, or both, for those who implement medical health care evaluation; (d) training health professionals in medical audit, both in the framework of their initial studies and in further education; and (e) offering quality information on health care evaluation to the population at large. There must be complete openness regarding evaluation to enable each member of French society to feel involved.
Medical audit is therefore taking on real shape in France, but many years will be needed for it to be developed nationally, to the point where it may fully play its part in regulating the health care system.
